BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 35806490)

  • 1. The Specific Role of Dermatan Sulfate as an Instructive Glycosaminoglycan in Tissue Development.
    Mizumoto S; Yamada S
    Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histories of Dermatan Sulfate Epimerase and Dermatan 4-
    Mizumoto S; Yamada S
    Genes (Basel); 2023 Feb; 14(2):. PubMed ID: 36833436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in the Pathophysiology of Musculocontractural Ehlers-Danlos Syndrome.
    Kosho T; Mizumoto S; Watanabe T; Yoshizawa T; Miyake N; Yamada S
    Genes (Basel); 2019 Dec; 11(1):. PubMed ID: 31905796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic heterogeneity and clinical variability in musculocontractural Ehlers-Danlos syndrome caused by impaired dermatan sulfate biosynthesis.
    Syx D; Van Damme T; Symoens S; Maiburg MC; van de Laar I; Morton J; Suri M; Del Campo M; Hausser I; Hermanns-Lê T; De Paepe A; Malfait F
    Hum Mutat; 2015 May; 36(5):535-47. PubMed ID: 25703627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiological Significance of Dermatan Sulfate Proteoglycans Revealed by Human Genetic Disorders.
    Mizumoto S; Kosho T; Yamada S; Sugahara K
    Pharmaceuticals (Basel); 2017 Mar; 10(2):. PubMed ID: 28346368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural alteration of glycosaminoglycan side chains and spatial disorganization of collagen networks in the skin of patients with mcEDS-CHST14.
    Hirose T; Takahashi N; Tangkawattana P; Minaguchi J; Mizumoto S; Yamada S; Miyake N; Hayashi S; Hatamochi A; Nakayama J; Yamaguchi T; Hashimoto A; Nomura Y; Takehana K; Kosho T; Watanabe T
    Biochim Biophys Acta Gen Subj; 2019 Mar; 1863(3):623-631. PubMed ID: 30553867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defect in dermatan sulfate in urine of patients with Ehlers-Danlos syndrome caused by a CHST14/D4ST1 deficiency.
    Mizumoto S; Kosho T; Hatamochi A; Honda T; Yamaguchi T; Okamoto N; Miyake N; Yamada S; Sugahara K
    Clin Biochem; 2017 Aug; 50(12):670-677. PubMed ID: 28238810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A decorin-deficient matrix affects skin chondroitin/dermatan sulfate levels and keratinocyte function.
    Nikolovska K; Renke JK; Jungmann O; Grobe K; Iozzo RV; Zamfir AD; Seidler DG
    Matrix Biol; 2014 Apr; 35():91-102. PubMed ID: 24447999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and pathophysiological delineation of musculocontractural Ehlers-Danlos syndrome caused by dermatan sulfate epimerase deficiency (mcEDS-DSE): A detailed and comprehensive glycobiological and pathological investigation in a novel patient.
    Minatogawa M; Hirose T; Mizumoto S; Yamaguchi T; Nagae C; Taki M; Yamada S; Watanabe T; Kosho T
    Hum Mutat; 2022 Dec; 43(12):1829-1836. PubMed ID: 35842784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss-of-function mutations of CHST14 in a new type of Ehlers-Danlos syndrome.
    Miyake N; Kosho T; Mizumoto S; Furuichi T; Hatamochi A; Nagashima Y; Arai E; Takahashi K; Kawamura R; Wakui K; Takahashi J; Kato H; Yasui H; Ishida T; Ohashi H; Nishimura G; Shiina M; Saitsu H; Tsurusaki Y; Doi H; Fukushima Y; Ikegawa S; Yamada S; Sugahara K; Matsumoto N
    Hum Mutat; 2010 Aug; 31(8):966-74. PubMed ID: 20533528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse Models of Musculocontractural Ehlers-Danlos Syndrome.
    Yoshizawa T; Kosho T
    Genes (Basel); 2023 Feb; 14(2):. PubMed ID: 36833362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic investigation of the skin in Chst14-/- mice: A model for skin fragility in musculocontractural Ehlers-Danlos syndrome caused by CHST14 variants (mcEDS-CHST14).
    Hirose T; Mizumoto S; Hashimoto A; Takahashi Y; Yoshizawa T; Nitahara-Kasahara Y; Takahashi N; Nakayama J; Takehana K; Okada T; Nomura Y; Yamada S; Kosho T; Watanabe T
    Glycobiology; 2021 Feb; 31(2):137-150. PubMed ID: 32601684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHST14/D4ST1 deficiency: New form of Ehlers-Danlos syndrome.
    Kosho T
    Pediatr Int; 2016 Feb; 58(2):88-99. PubMed ID: 26646600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular abnormalities in the placenta of Chst14-/- fetuses: implications in the pathophysiology of perinatal lethality of the murine model and vascular lesions in human CHST14/D4ST1 deficiency.
    Yoshizawa T; Mizumoto S; Takahashi Y; Shimada S; Sugahara K; Nakayama J; Takeda S; Nomura Y; Nitahara-Kasahara Y; Okada T; Matsumoto K; Yamada S; Kosho T
    Glycobiology; 2018 Feb; 28(2):80-89. PubMed ID: 29206923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of dermatan sulfate epimerase (DSE) function results in musculocontractural Ehlers-Danlos syndrome.
    Müller T; Mizumoto S; Suresh I; Komatsu Y; Vodopiutz J; Dundar M; Straub V; Lingenhel A; Melmer A; Lechner S; Zschocke J; Sugahara K; Janecke AR
    Hum Mol Genet; 2013 Sep; 22(18):3761-72. PubMed ID: 23704329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermatan sulfate epimerase 1-deficient mice have reduced content and changed distribution of iduronic acids in dermatan sulfate and an altered collagen structure in skin.
    Maccarana M; Kalamajski S; Kongsgaard M; Magnusson SP; Oldberg A; Malmström A
    Mol Cell Biol; 2009 Oct; 29(20):5517-28. PubMed ID: 19687302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myopathy Associated With Dermatan Sulfate-Deficient Decorin and Myostatin in Musculocontractural Ehlers-Danlos Syndrome: A Mouse Model Investigation.
    Nitahara-Kasahara Y; Posadas-Herrera G; Mizumoto S; Nakamura-Takahashi A; Inoue YU; Inoue T; Nomura Y; Takeda S; Yamada S; Kosho T; Okada T
    Front Cell Dev Biol; 2021; 9():695021. PubMed ID: 34708033
    [No Abstract]   [Full Text] [Related]  

  • 18. Alterations in glycosaminoglycan biosynthesis associated with the Ehlers-Danlos syndromes.
    Syx D; Delbaere S; Bui C; De Clercq A; Larson G; Mizumoto S; Kosho T; Fournel-Gigleux S; Malfait F
    Am J Physiol Cell Physiol; 2022 Dec; 323(6):C1843-C1859. PubMed ID: 35993517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ehlers Danlos Syndrome with Glycosaminoglycan Abnormalities.
    Miyake N; Kosho T; Matsumoto N
    Adv Exp Med Biol; 2021; 1348():235-249. PubMed ID: 34807422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Overview of
    Mizumoto S; Yamada S
    Front Cell Dev Biol; 2021; 9():764781. PubMed ID: 34901009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.